Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview - PubMed (original) (raw)

Review

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

S Chandler et al. J Neuroimmunol. 1997 Feb.

Abstract

The matrix metalloproteinases (MMPs) are a family of at least 14 zinc-dependent enzymes which are known to degrade the protein components of extracellular matrix. In addition, MMPs and related enzymes can also process a number of cell surface cytokines, receptors, and other soluble proteins. In particular we have shown that the release of the pro-inflammatory cytokine, tumor necrosis factor-alpha, from its membrane-bound precursor is an MMP-dependent process. MMPs are expressed by the inflammatory cells which are associated with CNS lesions in animal models of multiple sclerosis (MS) and in tissue from patients with the disease. MMP expression will contribute to the tissue destruction and inflammation in MS. Drugs which inhibit MMP activity are effective in animal models of MS and may prove to be useful therapies in the clinic.

PubMed Disclaimer

Similar articles

• The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
  Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. Lindberg RL, et al. Brain. 2001 Sep;124(Pt 9):1743-53. doi: 10.1093/brain/124.9.1743. Brain. 2001. PMID: 11522577
• [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
  Kurzepa J, Bartosik-Psujek H, Suchozebrska-Jesionek D, Rejdak K, Stryjecka-Zimmer M, Stelmasiak Z. Kurzepa J, et al. Neurol Neurochir Pol. 2005 Jan-Feb;39(1):63-7. Neurol Neurochir Pol. 2005. PMID: 15735992 Review. Polish.
• Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
  Clements JM, Cossins JA, Wells GM, Corkill DJ, Helfrich K, Wood LM, Pigott R, Stabler G, Ward GA, Gearing AJ, Miller KM. Clements JM, et al. J Neuroimmunol. 1997 Apr;74(1-2):85-94. doi: 10.1016/s0165-5728(96)00210-x. J Neuroimmunol. 1997. PMID: 9119983
• Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
  Leppert D, Lindberg RL, Kappos L, Leib SL. Leppert D, et al. Brain Res Brain Res Rev. 2001 Oct;36(2-3):249-57. doi: 10.1016/s0165-0173(01)00101-1. Brain Res Brain Res Rev. 2001. PMID: 11690622 Review.
• Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
  van Horssen J, Vos CM, Admiraal L, van Haastert ES, Montagne L, van der Valk P, de Vries HE. van Horssen J, et al. Neuropathol Appl Neurobiol. 2006 Dec;32(6):585-93. doi: 10.1111/j.1365-2990.2006.00766.x. Neuropathol Appl Neurobiol. 2006. PMID: 17083473

Cited by

• The Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy.
  Ljubisavljevic S, Stojanovic I, Basic J, Vojinovic S, Stojanov D, Djordjevic G, Pavlovic D. Ljubisavljevic S, et al. J Mol Neurosci. 2015 Aug;56(4):840-847. doi: 10.1007/s12031-015-0521-x. Epub 2015 Feb 22. J Mol Neurosci. 2015. PMID: 25702136
• Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis.
  Salmela MT, Pender SL, Reunala T, MacDonald T, Saarialho-Kere U. Salmela MT, et al. Gut. 2001 Apr;48(4):496-502. doi: 10.1136/gut.48.4.496. Gut. 2001. PMID: 11247893 Free PMC article.
• Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.
  Scaini G, Morais MO, Galant LS, Vuolo F, Dall'Igna DM, Pasquali MA, Ramos VM, Gelain DP, Moreira JC, Schuck PF, Ferreira GC, Soriano FG, Dal-Pizzol F, Streck EL. Scaini G, et al. Mol Neurobiol. 2014 Oct;50(2):358-67. doi: 10.1007/s12035-013-8618-0. Epub 2014 Jan 5. Mol Neurobiol. 2014. PMID: 24390570
• Response of glia, mast cells and the blood brain barrier, in transgenic mice expressing interleukin-3 in astrocytes, an experimental model for CNS demyelination.
  Powell HC, Garrett RS, Brett FM, Chiang CS, Chen E, Masliah E, Campbell IL. Powell HC, et al. Brain Pathol. 1999 Apr;9(2):219-35. doi: 10.1111/j.1750-3639.1999.tb00220.x. Brain Pathol. 1999. PMID: 10219739 Free PMC article.
• The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.
  Broekaart DW, Bertran A, Jia S, Korotkov A, Senkov O, Bongaarts A, Mills JD, Anink JJ, Seco J, Baayen JC, Idema S, Chabrol E, Becker AJ, Wadman WJ, Tarragó T, Gorter JA, Aronica E, Prades R, Dityatev A, van Vliet EA. Broekaart DW, et al. J Clin Invest. 2021 Jan 4;131(1):e138332. doi: 10.1172/JCI138332. J Clin Invest. 2021. PMID: 33141761 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information